Method and device for monitoring analyte concentration by optical detection

• US 7,248,906 B2
• Filed: 12/12/2002
• Issued: 07/24/2007
• Est. Priority Date: 12/17/2001
• Status: Expired due to Fees

• Current Assignee: P&V Consulting GmbH & Co. KG
• Original Assignee: Danfoss A/S
• Inventors: Dirac, Holger, Schweitz, Kasper Oktavio
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US10/499,596
• Publication Number:
  US 20050070770A1
• Time in Patent Office: 1,685 Days
• Field of Search: 600/310, 600/316, 600/322, 600/327, 600/341
• US Class Current: 600/316
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence

Abstract

A method and device are provided for the determination of the concentration of compounds in body tissue. The method utilises optical methods based on the interaction of light with compounds, whereby the concentration of the compound under analysis is determined. The method is especially suited for analysis for the concentration of glucose in blood or tissue of diabetic patients, a device being implanted underneath the skin of the patient and the method being carried out by using the implanted device. The device contains photo detectors at different levels connected by wires to an electronic circuit device. A differential analysis is performed on the signals from the detectors to reduce the effect of skin on the analysis.

Claims

1. A device for implantation beneath the skin of a living creature, the device having outer surfaces of biocompatible material and comprising:

detection means for detection of light transmitted through the skin, said detection means comprising;

at least one substantially flat first area including a first photodetector, and at least one substantially flat second area including a second photodetector, the arrangement of the first and second areas being such that light transmitted through the skin to the device interacts with compounds and tissues over a different distance between the skin and the first area than between the skin and the second area; and

transmitting means for transmitting signals derived from said detection means to an external device.

2. The device according to claim 1, wherein the detection means includes first and second groups of corresponding first and second areas the first group of areas forms a common first level, the second group of areas forms a common second level, and the common first and second levels have a predetermined spacing from each other to provide the difference in distance over which light interacts with compounds and tissue between the skin and the first and second areas.

3. The device according to claim 2, wherein the first group of areas is formed at a base level of the device and the second group of areas is formed by projections from the said base level to a top level.

4. The device according to claim 3, wherein the detection means further includes at least one substantially flat third area including a third photodetector, forming a common level between the base level and the top level.

5. The device according to claim 1, further including a spacer, covering at least one second area so that compounds and tissue are unable to fill a volume defined between the spacer and the at least one second area, the volume between the spacer and the at least one second area providing the difference in distance over which light interacts with compounds and tissue.

6. The device according to claim 1, wherein at least a part of one of said first and second areas is covered by a permeable membrane.

7. The device according to claim 6, wherein the membrane is permeable to glucose.

8. A method for optically detecting the content of a compound in the body of a living creature, the method comprising:

directing an external light source on different areas of an implanted device containing detection means, the distance, between the skin and said detection means, over which light from the light source interacts with compounds and tissue in respect of one area differing from the distance, between the skin and said detection means, over which light from the light source interacts with compounds and tissue in respect of another area;

obtaining light-representing signals representing the light directed at the different areas of said detection means; and

obtaining a value for the content of the compound by analysing the light-representing signals, the analysis being based on the difference between the light-representing signals from the different areas of the detection means.

9. The method according to claim 8, wherein the compound is glucose.

10. The method according to claim 8, wherein the value obtained is at least temporarily stored.

11. A method for optically detecting the content of a compound in the body of a living creature, the method comprising:

directing an external light source on different areas of an implanted device containing detection means;

obtaining light-representing signals by means of said detection means;

transmitting said light-representing signals to an external device; and

obtaining a value for the content of the compound by analysing the light-representing signals, the analysis being based on the difference between the light-representing signals from the different areas of the detection means.

12. The method according to claim 11, wherein the compound is glucose.

13. The method according to claim 11, wherein the value obtained is at least temporarily stored.

14. A subcutaneous implant comprising:

an implant body having a first and a second level;

a first and a second light detector arranged, respectively, at the first and second levels, and facing in a substantially similar direction; and

transmitting means for transmitting a signal derived from the light detectors to an external device;

wherein the first and second levels are separated in the direction the first and second light detectors are facing, such that light propagating from an external source toward the implant body with substantially perpendicular incidence to the first and second light detectors must travel a longer distance to reach the first light detector than the second light detector.

15. The implant of claim 14, wherein the first and second light detectors are arranged in first and second light wells defined, respectively, within the first and second levels.

16. The implant of claim 14, wherein the first and second light detectors are arranged on substantially flat services formed at their respective levels.

17. The implant of claim 14, further comprising:

a third light detector arranged at the first level, a first calibration volume above the third light detector extending to the level of the second light detector being surrounded by a portion of the implant body;

a first diffusion-proof lid covering the first calibration volume above the third light detector, the first diffusion-proof lid being transparent to the light from the external light source; and

a first medium having a known concentration of a compound located in the first calibration volume above the third light detector.

18. The implant of claim 17, further comprising:

a fourth light detector arranged at the first level, a second calibration volume above the fourth light detector extending to the level of the second light detector being surrounded by another portion of the implant body;

a second diffusion-proof lid covering the second calibration volume above the fourth light detector, the second diffusion-proof lid being transparent to the light from the external light source; and

a second medium having a known concentration of a compound located in the second calibration volume above the fourth light detector;

wherein the concentrations in the first and second medium correspond, respectively, to upper and lower ends of a required measurement range for the compound.

19. A subcutaneous implant comprising:

a base;

a first and a second light detector arranged on the base facing in substantially the same direction;

a spacer mounted on the base over the second light detector, the spacer being transparent to light from an external light source and defining a volume in which no interaction of light with tissues and compounds occurs; and

transmitting means for transmitting a signal derived from the light detectors to an external device;

wherein, with the implant implanted under the skin such that the first and second light detectors are a substantially equal distance from the skin, the light from the external light source interacts with compounds and tissues over a longer distance before reaching the first light detector than the second light detector, due, at least in part, to the volume defined by the spacer.

20. The implant of claim 19, wherein the spacer is included in a top plate mounted on the base, the volume being formed by a recess in the top plate.